Vitamin B6 Treatment for Gyrate Atrophy of the Retina
Author Information
Author(s): Javadzadeh Alireza, Gharabaghi Davood
Primary Institution: Tabriz University of Medical Sciences, Tabriz, Iran
Hypothesis
Can high doses of Vitamin B6 reduce serum ornithine levels in patients with gyrate atrophy of the retina?
Conclusion
The patient's serum ornithine level significantly decreased after treatment with Vitamin B6, indicating a potential response to this therapy.
Supporting Evidence
- The patient had a high serum ornithine level of 629 nmol/mL before treatment.
- After six months of Vitamin B6 treatment, the serum ornithine level decreased to 293 nmol/mL.
- Only a small percentage of patients with gyrate atrophy respond to Vitamin B6 supplementation.
Takeaway
A 28-year-old man with a rare eye condition had high levels of a substance called ornithine, but after taking Vitamin B6 for six months, his levels went down a lot, which is a good sign.
Methodology
The patient was treated with 300 mg/day of Vitamin B6 for six months, and serum ornithine levels were measured before and after treatment.
Limitations
The exact mechanism of the condition and the response to treatment is not fully understood, and only a small percentage of patients respond to Vitamin B6.
Participant Demographics
One 28-year-old male patient.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website